1 results match your criteria: "Global Medical and Clinical Affairs Radiology[Affiliation]"
Acta Radiol
July 2014
Global Medical and Clinical Affairs Radiology, Bayer HealthCare, Berlin, Germany.
Background: Determining the safety of contrast agents is challenging. In the absence of large controlled clinical trials, non-interventional (post-marketing surveillance) studies provide an opportunity to clearly investigate the safety profile of contrast agents.
Purpose: To assess the safety profile of iopromide in contrast-enhanced X-ray in clinical practice, using pooled data from three non-interventional studies.